Clariane SE (EPA:CLARI)
France · Delayed Price · Currency is EUR | Market Cap | 1.43B -23.5% |
| Revenue (ttm) | 5.31B +0.5% |
| Net Income | 1.60M |
| EPS | 0.00 |
| Shares Out | 356.50M |
| PE Ratio | 898.51 |
| Forward PE | 17.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 158,110 |
| Open | 3.974 |
| Previous Close | 3.970 |
| Day's Range | 3.904 - 4.040 |
| 52-Week Range | 3.270 - 5.395 |
| Beta | 0.82 |
| Analysts | Buy |
| Price Target | 4.90 (+21.89%) |
| Earnings Date | Jul 29, 2026 |
About Clariane SE
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for CLARI stock is "Buy." The 12-month stock price target is €4.90, which is an increase of 21.89% from the latest price.
News
Clariane SE Earnings Call Transcript: Q1 2026
Solid organic revenue growth of +4.9% in Q1 2026 was driven by improved occupancy, pricing, and strong performance across all segments and geographies. Liquidity was strengthened by a successful EUR 500 million bond issue, and medium-term guidance was confirmed.
Clariane SE Earnings release: Q1 2026
Clariane SE released its Q1 2026 earnings on April 24, 2026, summarizing the period's financial results.
Clariane SE Slides: Q1 2026
Clariane SE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 24, 2026.
Clariane SE Earnings Call Transcript: Q4 2025
Delivered strong 2025 results with 4.5% organic revenue growth, improved profitability, and reduced leverage. Strategic divestments, cost efficiency programs, and a robust outlook support continued margin and cash flow gains through 2028.
Clariane SE Annual report: Q4 2025
Clariane SE has published its Q4 2025 annual report on February 27, 2026.
Clariane SE Earnings release: Q4 2025
Clariane SE released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
Clariane SE Slides: Q4 2025
Clariane SE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Clariane SE Earnings Call Transcript: Q3 2025
Revenue grew 4.9% organically in the first nine months of 2025, with Q3 acceleration and all segments contributing. EBITDA margin is set to reach ~12% in H2, supported by cost reduction and portfolio streamlining, while leverage and CapEx guidance remain unchanged.
Clariane SE Earnings release: Q3 2025
Clariane SE released its Q3 2025 earnings on October 28, 2025, summarizing the period's financial results.
Clariane SE Slides: Q3 2025
Clariane SE has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 28, 2025.
Clariane SE Earnings Call Transcript: Q2 2025
Solid H1 2025 results with 4.8% organic revenue growth, successful €1B asset disposal, and strengthened liquidity. Guidance for 6–9% EBITDA growth and leverage below 5.5x is confirmed, with margin recovery expected in H2 from pricing and operational improvements.
Clariane SE Quarterly report: Q2 2025
Clariane SE has published its Q2 2025 quarterly earnings report on July 30, 2025.
Clariane SE Earnings release: Q2 2025
Clariane SE released its Q2 2025 earnings on July 30, 2025, summarizing the period's financial results.
Clariane SE Slides: Q2 2025
Clariane SE has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 30, 2025.